The red-hot mergers-and-acquisitions market of the last several years cooled during the first half of 2016.
The slowdown, following a couple annual records for deals and dollar volumes, was typical amid uncertainty over the pending U.S. presidential election, rising prices in a frothy market and concerns that most of the good targets already are taken.
Prices have reached 10-year highs, Bloomberg reported recently, as buyers seek growth through acquisitions in a low-inflation, slow-growth environment in many industries. Acquirers paid a median of 11 times target companies EBIDTA — or earnings before interest, taxes, depreciation and amortization.
"Things have slowed down a bit but not enough so that people are worried," said Bill Jonason, a veteran mergers-and-acquisition attorney at Dorsey & Whitney in Minneapolis. "Total deals in terms of numbers and value were down in the first half of 2016. Some of that is because 2014 and 2015 were really good years.
"Maybe 2016 will just get back to normal. I'm busy working on deals that likely will close in the second half of the year."
Nationally, there were 4,937 transactions during the first half valued at $757.3 billion, compared with 5,321 deals valued at $910.74 billion during the first six months of 2015, according to Dealogic, which tracks mergers and public stock offerings.
In Minnesota, there were 92 deals so far this year, compared to 101 during the first half of last year. However, the value of the transactions in which a Minnesota firm was a buyer or seller rose in 2016 to $52.5 billion from $20.9 billion during the first six months of 2015.
The value uptick was driven by two large transactions among public companies: Valspar's $11.3 billion sale of the coatings manufacturer to rival Sherwin-Williams. And St. Jude Medical's $25 billion sale to Abbott Laboratories.